Cell Injury Mechanisms and Morphologic Patterns

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Cell injury is classified as reversible or irreversible, with the latter leading to cell death via necrosis or apoptosis; the transition is marked by sustained ATP depletion and loss of mitochondrial membrane integrity, leading to irreversible damage.
• Key biochemical targets of injury include ATP depletion, mitochondrial dysfunction, calcium homeostasis disruption, membrane damage, and reactive oxygen species accumulation, which form interconnected pathways that amplify cellular damage.
• Morphologic patterns of reversible injury include cellular swelling and fatty change, while irreversible injury is characterized by nuclear changes (pyknosis, karyorrhexis, karyolysis) in necrosis, and cell shrinkage with apoptotic bodies in apoptosis, with necrosis typically eliciting inflammation and apoptosis usually not.
• Diagnostic assessment relies on gross examination, light microscopy for pattern recognition (nuclear changes, cell swelling vs. shrinkage, inflammation), and potentially ancillary tests like caspase-3 immunohistochemistry or TUNEL assays for apoptosis confirmation.
• Species and organ-specific differences significantly influence the rate of autolysis and the morphologic presentation of injury (e.g., liquefactive necrosis in brain vs. coagulative necrosis in kidney), necessitating interpretation within this context.
• Common diagnostic errors include misinterpreting autolysis as necrosis, sampling error missing the most affected area, and misclassifying apoptosis as necrosis or vice versa, which can be mitigated by correlating histologic findings with clinical history, gross appearance, and ancillary data.

Cell injury is the structural and functional response of cells to stress, whether from hypoxia, toxins, infectious agents, immune-mediated attack, or physical trauma. This article provides the conceptual foundation for recognizing and interpreting the morphologic patterns of reversible and irreversible cell injury across species. It is written for veterinary students who have completed introductory histology and physiology and who now need a systematic framework for understanding why cells die, how they die, and what dying cells look like under the microscope. The material bridges basic pathobiology and the diagnostic reasoning used in necropsy and biopsy interpretation.

The central distinction in this field is between reversible and irreversible injury. Reversible injury preserves the capacity for recovery once the inciting cause is removed. Irreversible injury commits the cell to death, either by necrosis or apoptosis, regardless of subsequent intervention. The morphologic features that separate these states are not always absolute, but they follow predictable patterns that the pathologist can recognize. Understanding the mechanisms that drive the transition from reversible to irreversible injury is essential for interpreting histologic sections and for anticipating the clinical consequences of ischemic, toxic, and traumatic events.

At a Glance

Causes and General Mechanisms of Cell Injury

The causes of cell injury fall into several broad categories: oxygen deprivation, physical agents, chemical agents and drugs, infectious agents, immunologic reactions, genetic derangements, and nutritional imbalances. Hypoxia is the most common cause of cell injury in clinical practice, arising from ischemia, hypoxemia, reduced oxygen-carrying capacity of blood, or impaired tissue perfusion. Ischemia, the reduction of blood flow, is particularly damaging because it also impairs the delivery of substrates and the removal of metabolic waste products.

The biochemical targets of injury are shared across etiologies. ATP depletion, mitochondrial dysfunction, loss of calcium homeostasis, membrane damage, and accumulation of reactive oxygen species form an interconnected network of injury pathways. These pathways amplify one another. ATP depletion impairs the sodium-potassium pump, causing sodium and water to enter the cell. Calcium influx activates phospholipases, proteases, and endonucleases. Reactive oxygen species peroxidate membrane lipids and oxidize proteins and DNA. The relative contribution of each pathway depends on the inciting cause and the cell type affected.

ATP Depletion and the Transition to Irreversible Injury

ATP is the currency of cellular survival. It powers membrane pumps, synthetic reactions, and the maintenance of ionic gradients. When ATP falls below approximately 5 to 10 percent of normal levels, the cell cannot sustain these functions. The sodium-potassium ATPase fails, sodium accumulates intracellularly, and water follows by osmosis. The endoplasmic reticulum swells because its calcium pump fails, and ribosomes detach from the rough endoplasmic reticulum as protein synthesis declines.

The switch to anaerobic glycolysis generates ATP but produces lactic acid, lowering intracellular pH. Mild acidosis is initially protective because it inhibits some degradative enzymes, but severe acidosis damages organelles and lysosomal membranes. The point of no return is reached when mitochondrial function is irreversibly lost. Mitochondrial permeability transition, the opening of a large conductance pore in the inner mitochondrial membrane, collapses the proton gradient and halts oxidative phosphorylation. This event is a critical threshold for cell death. Once mitochondria lose membrane integrity, the cell cannot recover even if blood flow is restored.

Mitochondrial Pathways and the Balance of Survival and Death Signals

Mitochondria are also energy generators. They are also the central integrators of cell death signals. The outer mitochondrial membrane contains members of the Bcl-2 family of proteins, which regulate the release of pro-apoptotic factors such as cytochrome c into the cytosol. Anti-apoptotic proteins including Bcl-2 and Bcl-xL preserve mitochondrial membrane integrity, while pro-apoptotic proteins such as Bax promote permeabilization. A shift in the balance between these opposing factors toward the expression of death-promoting proteins is one recognized mechanism of apoptotic cell death, as described in reviews of apoptosis after traumatic brain injury.

Cytochrome c release into the cytosol triggers assembly of the apoptosome, which activates caspase cascades and commits the cell to apoptosis. This pathway is energy-dependent and requires functional ATP. Consequently, cells with severe ATP depletion tend to die by necrosis, while cells with partial ATP preservation may die by apoptosis. The same injurious stimulus can produce both morphologies in adjacent cells, a finding documented in studies of cell death mechanisms following traumatic brain injury, where both apoptotic and necrotic neurons are present within contusions in the acute post-traumatic period.

Calcium, Membrane Damage, and Reactive Oxygen Species

Cytosolic calcium is maintained at extremely low concentrations by membrane pumps and intracellular sequestration. Injury to the plasma membrane or endoplasmic reticulum allows calcium to flood the cytosol. Elevated calcium activates phospholipases that degrade membrane phospholipids, proteases that dismantle the cytoskeleton and membrane proteins, and endonucleases that fragment chromatin. These enzymes are largely responsible for the morphologic changes seen in necrotic cells.

Reactive oxygen species are produced normally during oxidative phosphorylation and are neutralized by cellular antioxidants. Injury overwhelms these defenses. Lipid peroxidation damages membrane phospholipids, protein oxidation inactivates enzymes, and DNA damage triggers repair mechanisms that consume ATP. The plasma membrane is a major target. Loss of membrane integrity is the defining feature of irreversible injury because it permits the escape of intracellular contents and the influx of extracellular material, including calcium, which accelerates the degradative cascade.

Morphologic Patterns of Reversible Injury

Two morphologic patterns dominate reversible injury: cellular swelling and fatty change. Cellular swelling is the earliest manifestation of injury and is visible by light microscopy as cytoplasmic pallor, vacuolation, and swelling of organelles. The cell enlarges, and the cytoplasm becomes increasingly clear as water accumulates. This change is reversible if the inciting cause is removed before membrane damage occurs.

Fatty change, or steatosis, occurs when cells accumulate lipid vacuoles in the cytoplasm. It is most commonly seen in the liver, where impaired lipid metabolism accompanies hypoxic or toxic injury. The lipid appears as clear vacuoles in routine hematoxylin and eosin sections because the fat is dissolved during processing. Fatty change is reversible, but it indicates a significant metabolic disturbance and may progress to irreversible injury if the cause persists.

Morphologic Patterns of Irreversible Injury

Necrosis is the morphologic expression of cell death in a living animal, characterized by the action of degradative enzymes on lethally injured cells. The classic nuclear changes are pyknosis, nuclear shrinkage and increased basophilia, karyorrhexis, fragmentation of the nucleus, and karyolysis, dissolution of the nucleus by DNase activity. Cytoplasmic changes include increased eosinophilia due to protein denaturation and loss of RNA, and loss of cell outline as membranes degrade.

Apoptosis produces a different morphology. The cell shrinks, the chromatin condenses in crescentic masses beneath the nuclear membrane, and the cell fragments into apoptotic bodies that are phagocytosed by neighboring cells or macrophages. Because apoptotic cells do not release their contents, inflammation is typically absent. In tissues, apoptosis often affects scattered single cells, whereas necrosis tends to involve contiguous sheets of cells. Both patterns can coexist in the same lesion, as observed in neuropathologic assessments of vascular cognitive impairment, where ischemic injury produces regional patterns of cell death that vary with the severity and duration of the insult.

The distinction between necrosis and apoptosis has therapeutic implications. Necrosis is a passive, unregulated process that inevitably elicits inflammation and tissue repair. Apoptosis is an active, gene-directed process that can, in principle, be modulated. In diseases such as pulmonary fibrosis, the apoptosis paradox of myofibroblast resistance to cell death illustrates how dysregulation of apoptotic pathways contributes to chronic disease. Recognition of the dominant cell death mode in a lesion therefore informs both prognosis and potential therapeutic targets.

Practical Assessment of Cell Injury: From Biopsy to Diagnosis

The diagnostic evaluation of cell injury begins with a question: is the process reversible, and what is the dominant mechanism? The answer determines prognosis, further testing, and therapeutic direction. A systematic approach integrates gross findings, histologic features, and, when indicated, ancillary techniques such as immunohistochemistry or electron microscopy.

Stepwise Evaluation of Tissue Samples

Step 1: Gross examination and sample selection. The gross lesion dictates which areas are sampled. In an infarct, the periphery contains the transition zone between viable and irreversibly injured tissue, while the center shows coagulative necrosis. In a suspected toxic injury, sample the organ with the highest metabolic activation, often the liver, and include both affected and grossly normal parenchyma. For brain injury, sample the contusion core, the penumbra, and remote white matter tracts, because apoptotic neurons appear in regions distant from the impact site in the days after trauma.

Step 2: Histologic pattern recognition. The first decision is whether cells are alive or dead. Reversible injury shows swelling, vacuolation, and loss of surface specializations, but the nucleus remains intact. Irreversible injury is defined by nuclear changes: pyknosis, karyorrhexis, or karyolysis. The second decision is the pattern of cell death. Necrosis is characterized by cell swelling, membrane rupture, and an inflammatory response. Apoptosis shows cell shrinkage, chromatin condensation, and formation of apoptotic bodies without inflammation. In traumatic brain injury, both morphologies coexist within the same lesion, and dying neural cells exhibit either an apoptotic or a necrotic morphology.

Step 3: Ancillary testing. Routine hematoxylin and eosin staining resolves most cases. When apoptosis is suspected but the morphology is ambiguous, consider:

• Caspase-3 immunohistochemistry, which labels cells committed to the apoptotic pathway.
• TUNEL assay, which detects DNA fragmentation. This method does not distinguish apoptosis from autolysis or necrosis, so interpret it alongside morphology.
• Electron microscopy for definitive ultrastructural features, reserved for cases where the diagnosis changes management.

Distinguishing Reversible from Irreversible Injury

The morphologic distinction between reversible and irreversible injury is the central decision in diagnostic pathology. The table below summarizes the features that separate the two states.

The transition from reversible to irreversible injury is not a single event but a cascade. Loss of membrane integrity is the point of no return, because it allows calcium influx, mitochondrial permeability transition, and release of pro-apoptotic factors. In practice, the presence of nuclear change is the most reliable light microscopic indicator of irreversibility.

Flowchart for Morphologic Diagnosis

The following decision tree structures the diagnostic approach.

1. Is the cell alive or dead?
2. Alive: nucleus intact, cytoplasm shows swelling or vacuolation. Diagnosis: reversible injury. Identify the cause and remove it.
3. Dead: nuclear pyknosis, karyorrhexis, or karyolysis. Proceed to step 2.
4. Is the death pattern necrosis or apoptosis?
5. Necrosis: cell swelling, membrane rupture, inflammation. Proceed to step 3.
6. Apoptosis: cell shrinkage, apoptotic bodies, no inflammation. Proceed to step 4.
7. Mixed pattern: both features present. This is common in trauma and ischemia. Proceed to steps 3 and 4.
8. What is the pattern of necrosis?
9. Coagulative: architecture preserved, typical of ischemia in most organs.
10. Liquefactive: tissue liquefies, typical of brain and abscesses.
11. Caseous: amorphous debris, typical of mycobacterial and fungal infections.
12. Fat necrosis: saponification, seen in pancreatic injury.
13. Fibrinoid: vessel wall necrosis with protein deposition.
14. What is the trigger for apoptosis?
15. Ischemia or trauma: excitotoxicity, calcium overload, free radical generation.
16. Toxin or drug: direct DNA damage or mitochondrial injury.
17. Immune-mediated: cytotoxic T cells or antibody-dependent mechanisms.
18. Withdrawal of growth factors: atrophy of hormone-dependent tissues.

Species and System Considerations

The correct diagnostic approach changes with the species, the organ, and the clinical context.

Species differences. The rate of autolysis after death varies widely. The liver of a pig autolyzes rapidly, while the same tissue in a dog remains interpretable for longer. Postmortem samples must be collected promptly, and the pathologist must know the interval between death and fixation. In production animals, the cost of diagnostic workup is weighed against the value of the animal and the herd. A single necropsy in a feedlot may justify a treatment change for the entire pen, while the same workup in a companion animal is justified by the individual patient.

Organ-specific patterns. The brain responds to ischemia with liquefactive necrosis, while the kidney shows coagulative necrosis. The myocardium requires 4 to 6 hours of ischemia before light microscopic changes appear, but electron microscopy detects mitochondrial damage within minutes. The lung shows a mixed pattern of alveolar epithelial injury and interstitial inflammation, and in fibrosing disease, alveolar epithelial cell injury and apoptosis are consistent ultrastructural findings.

Patient status. A chronically debilitated animal may show autolysis that mimics necrosis. An immunosuppressed animal may lack the inflammatory response that normally accompanies necrosis, making the lesion appear apoptotic. A neonate has a different complement of antioxidant defenses than an adult, so the same toxin produces different patterns of injury.

Documentation and Reporting

The pathology report must record the following for each lesion:

• Location and distribution: focal, multifocal, or diffuse.
• Pattern of injury: reversible or irreversible, necrosis or apoptosis.
• Severity: mild, moderate, or marked, with a defined grading scheme.
• Duration: acute, subacute, or chronic, based on the inflammatory infiltrate and repair response.
• Cause, if identifiable: ischemia, toxin, trauma, or infection.

Photographs should be taken at low and high magnification, with a scale bar. The report should state which ancillary tests were performed and how they were interpreted. When the cause is uncertain, the report should list differential diagnoses in order of likelihood and recommend additional testing. The Davis-Thompson Foundation veterinary pathology resources provide case material and teaching collections that illustrate the spectrum of injury patterns across species.

When the Diagnosis Remains Uncertain

Some cases do not resolve with routine histology. The lesion may be too small, the tissue too autolyzed, or the injury too early to produce morphologic change. In these situations, the pathologist should:

• Request additional samples from the margins of the lesion.
• Perform special stains for organizms, iron, or amyloid.
• Use immunohistochemistry to characterize the inflammatory infiltrate or to confirm apoptosis.
• Correlate the histologic findings with clinical pathology data, such as serum enzyme activities or imaging findings.

The MSD Veterinary Manual provides species-specific guidance on sample collection and interpretation that supports this correlation. When the evidence base is limited, the report should state the degree of certainty and recommend a monitoring plan instead of a definitive diagnosis.

Recognized Complications and Early Detection

The principal failure mode in cell injury assessment is misclassification of the injury phase, which leads to incorrect prognostication. Reversible injury may be mistaken for irreversible change when sampling occurs during the early stages of necrosis, before nuclear karyolysis and karyorrhexis become apparent. Conversely, autolysis in a delayed postmortem sample can mimic antemortem necrosis. Early detection of this error requires correlation between histologic findings and the clinical timeline, tissue preservation quality, and the gross appearance of the organ at necropsy.

A second recognized complication is sampling error. A single biopsy may miss the most severely affected region of an organ, particularly when injury is zonal or multifocal. The discriminating check is to compare the biopsy findings with clinical biochemistry, imaging findings, and gross lesions. Where the sample is small, the pathologist should state the limitation explicitly in the report.

A third failure mode is the misinterpretation of apoptosis as necrosis, or the reverse. Apoptotic bodies are often phagocytosed rapidly and may be sparse even in tissues with substantial cell loss. Conversely, secondary necrosis of apoptotic cells can produce a morphologic picture that resembles primary necrosis. The distinction matters because the mechanisms differ, and the therapeutic implications for conditions such as pulmonary fibrosis depend on whether epithelial cell loss is driven by apoptosis or by other pathways. The evolving concepts of apoptosis in idiopathic pulmonary fibrosis illustrate how the same cell death pathway can have opposing roles in different cell populations within one disease process.

Common Errors and Corrective Actions

Less experienced clinicians frequently overinterpret cytoplasmic eosinophilia and nuclear pyknosis as definitive evidence of necrosis without considering the possibility of autolysis or poor fixation. The corrective action is to assess the tissue architecture as a whole. If the stroma is intact and the inflammatory response is absent, the changes may be agonal or postmortem instead of antemortem injury.

A second common error is the assumption that a single mechanism explains all cell death in a lesion. Traumatic brain injury, for example, produces both apoptotic and necrotic cell death, with the relative contribution of each varying by region and time after injury. The regional and temporal patterns of apoptotic and necrotic cell death following traumatic brain injury demonstrate that both morphologies can coexist within the same contusion. The corrective action is to describe what is present instead of to force the findings into one category.

A third error is the failure to recognize that vascular injury contributes to parenchymal damage. Blood-brain barrier breakdown after trauma is also a consequence of neuronal injury but can initiate transcriptional changes that lead to delayed neuronal dysfunction. The role of blood-brain barrier breakdown in the initiation of delayed neuronal dysfunction requires the clinician to consider vascular pathology as a primary driver, not an epiphenomenon.

Troubleshooting Table

Limitations of Current Evidence

The evidence base for cell injury mechanisms is uneven across species and organ systems. Much of the mechanistic work derives from rodent models and human tissue, and direct extrapolation to domestic species requires caution. The neurovascular mechanisms described in Alzheimer's disease research illustrate how vascular dysfunction can precede parenchymal injury, but whether the same sequence applies in veterinary patients with chronic cognitive dysfunction is not established.

Expert opinion still differs on the threshold at which reversible injury becomes irreversible. The classic morphologic criteria, such as the point of no return in ATP depletion, are well described in experimental systems, but their translation to clinical biopsy material is imprecise. Some pathologists emphasize mitochondrial permeability transition as the critical event, while others focus on membrane disruption. Both views are defensible, and the practical consequence is that the diagnosis of irreversible injury rests on morphologic features instead of on a single molecular marker.

The role of apoptosis in chronic disease is similarly contested. In some conditions, apoptosis is clearly pathogenic, while in others it may represent an appropriate homeostatic response. The apoptosis paradox in idiopathic pulmonary fibrosis, where epithelial cells undergo apoptosis while myofibroblasts become resistant to it, shows that the same pathway can have opposing effects within one lesion.

Referral, Consultation, and Reporting

Referral to a veterinary pathologist is warranted when the biopsy sample is small, when the lesion is unusual, or when the distinction between reversible and irreversible injury affects treatment decisions. The Davis-Thompson Foundation veterinary pathology resources provide case material and diagnostic teaching collections that can support interpretation of challenging cases. For species-specific guidance on sample handling and interpretation, the MSD Veterinary Manual offers peer-reviewed reference material.

Laboratory involvement is appropriate when toxic injury is suspected, when infectious agents may be present, or when immunohistochemistry is needed to characterize cell populations. Regulatory reporting may be required for notifiable diseases, and the WOAH terrestrial animal health standards define the international framework for such reporting. The American Veterinary Medical Association practice resources provide guidance on professional obligations in the United States.

When the diagnosis remains uncertain after histologic evaluation, the pathologist should state the differential diagnoses explicitly and recommend additional testing instead of forcing a definitive conclusion. This is not a failure of the diagnostic process but a recognition of the limits of morphologic assessment.

Frequently Asked Questions

How Do I Choose Between Apoptosis and Necrosis When the Morphology Is Ambiguous?

When light microscopy is equivocal, examine the tissue context and the pattern of cell loss. Apoptotic cells appear as single, shrunken cells with condensed chromatin and intact membranes, often without an associated inflammatory response. Necrosis typically affects contiguous groups of cells, produces cytoplasmic eosinophilia and karyolysis, and elicits inflammation. In traumatic brain injury, dying neural cells exhibit either apoptotic or necrotic morphology, and both patterns can coexist within the same lesion, as described in institutional reviews of cell death mechanisms following traumatic brain injury. If the distinction matters for prognosis, consider ancillary testing such as caspase immunohistochemistry or TUNEL, but interpret these cautiously because they can label cells undergoing other forms of death.

What Can I Do When I Lack Access to Electron Microscopy or Special Stains?

Light microscopy with routine hematoxylin and eosin staining answers most diagnostic questions. Assess nuclear changes, cytoplasmic tinctorial shifts, and the distribution of affected cells. If you suspect apoptosis but cannot confirm it, describe what you see and note the differential. The Davis-Thompson Foundation veterinary pathology resources provide case material and diagnostic teaching collections that can help you build interpretive confidence. For difficult cases, consider submitting tissue to a diagnostic laboratory with immunohistochemistry capabilities. Frozen sections are adequate for detecting acute necrosis but poor for subtle apoptotic changes. Document your method and its limitations in the record.

How Does the Interpretation of Cell Injury Change Between Species?

The fundamental mechanisms are conserved across mammals, but the morphologic expression and time course differ. Hepatocytes in dogs and cats accumulate lipid more readily than those in ruminants under similar metabolic stress. Cardiac myocyte injury in horses may show contraction band necrosis earlier than in small animals. Neuronal vulnerability to ischemia varies by region and species, and the balance between apoptotic and necrotic death after trauma shifts with injury severity and time, as reviewed in publications on apoptosis after traumatic brain injury. Always interpret lesions against species-specific normal histology. The MSD Veterinary Manual, Professional Edition offers species-specific guidance on expected findings and common artifacts.

What Should I Record in the Biopsy Report When the Pattern Is Mixed?

State the dominant pattern first, then list secondary findings in order of extent. Use standard terms such as acute coagulative necrosis, apoptosis, or chronic progressive changes. Record the distribution as focal, multifocal, or diffuse, and note whether the process is active or resolving. Include a morphologic diagnosis and a separate interpretive comment. If you cannot determine reversibility, say so explicitly and list the findings that support each possibility. The AVMA practice resources provide guidance on professional reporting standards. A clear record allows a second pathologist to review the case without repeating the full workup.

How Do I Explain an Uncertain Diagnosis to the Client or Referring Veterinarian?

Be direct about what is known and what is not. State that the tissue shows evidence of cell injury, describe the pattern in plain terms, and explain that the underlying cause may require additional testing. Avoid overstating the certainty of a mechanism you inferred from morphology alone. For example, you can say the cells show features consistent with apoptosis, but the trigger is unknown. If the lesion has prognostic significance, such as the apoptosis paradox in fibrotic lung disease where myofibroblasts resist death while epithelial cells die, explain that the pattern matters clinically even when the cause is unclear, as discussed in reviews of apoptosis in idiopathic pulmonary fibrosis. Offer next steps and a timeline.

When Should I Refer a Case for a Second Opinion or Advanced Testing?

Refer when the diagnosis changes management, when the lesion is unusual for the species and tissue, or when the client requests confirmation. Also refer if you suspect an error in sampling or processing. Advanced testing is most useful when the distinction between apoptosis and necrosis, or between reversible and irreversible injury, affects treatment or prognosis. In traumatic brain injury, blood-brain barrier breakdown contributes to delayed neuronal dysfunction, and identifying vascular injury may alter case management, as noted in reviews of blood-brain barrier breakdown in traumatic brain injury. If your laboratory cannot perform the needed test, ask the referral laboratory which fixative and transport conditions they require before sending tissue.

Related Clinical & Scientific Guides

• Hypersensitivity Reactions: Types and Mechanisms
• Therapeutic Decision-Making for Respiratory Infections in Cattle
• Monitoring Fluid Therapy in Critically Ill Veterinary Patients

References and Further Reading

• Cell death mechanisms following traumatic brain injury.. 2004.
• Apoptosis after traumatic brain injury.. 2000.
• Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.. 2009.
• Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.. 2016.
• Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.. 2006.
• Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.. 2010.
• Davis-Thompson Foundation Veterinary Pathology Resources. Davis-Thompson Foundation.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Environmental Toxins and Mechanisms of Cellular Injury
• Edema and Shock: Pathophysiologic Mechanisms
• Chronic Inflammation: Causes and Morphologic Features
• Neoplasia: Mechanisms of Carcinogenesis and Classification
• Genetic Diseases in Animals: Mechanisms and Examples

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.